Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Zomestine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zomestine 10mg modified-release tablets
0407020ADBNADAF
|
Zomestine | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Zomestine 20mg modified-release tablets
0407020ADBNAEAG
|
Zomestine | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Zomestine 40mg modified-release tablets
0407020ADBNABAH
|
Zomestine | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Zomestine 5mg modified-release tablets
0407020ADBNACAK
|
Zomestine | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Zomestine 80mg modified-release tablets
0407020ADBNAAAI
|
Zomestine | Oxycodone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.